Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-033693
Filing Date
2020-02-13
Accepted
2020-02-13 06:02:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d882500dsc13ga.htm SC 13G/A 43972
  Complete submission text file 0001193125-20-033693.txt   45345
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Subject) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59335 | Film No.: 20606744
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2609 CALDWELL MILL LN BIRMINGHAM AL 35243
Business Address
SATTERFIELD THOMAS A JR (Filed by) CIK: 0001132317 (see all company filings)

Type: SC 13G/A